2023 to 2024 Seasonal Influenza Vaccine Effective for Reducing Risk
VE against influenza-linked outpatient visits ranged from 33 to 49 percent, and against hospitalization from 41 to 44 percent among adults
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.